Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Joshua Walczak"'
Autor:
Matthew R. Reynolds, David J. Cohen, Katherine Vilain, Lars G. Svensson, Haiyan Li, D. Craig Miller, Partner Investigators, Craig R. Smith, Joseph E. Bavaria, Kaijun Wang, Martin B. Leon, Lowell E. Satler, Vinod H. Thourani, Duane S. Pinto, Elizabeth A. Magnuson, Michael J. Mack, Joshua Walczak, Yang Lei
Publikováno v:
Journal of the American College of Cardiology. 60:2683-2692
Objectives The aim of this study was to evaluate the cost-effectiveness of transcatheter aortic valve replacement (TAVR) compared with surgical aortic valve replacement (AVR) for patients with severe aortic stenosis and high surgical risk. Background
Autor:
Elizabeth A. Magnuson, Matthew R. Reynolds, Martin B. Leon, John M. Lasala, William W. O'Neill, Yang Lei, Charles J. Davidson, Susheel Kodali, Joshua Walczak, Craig R. Smith, Kaijun Wang, David J. Cohen, Katherine Vilain
Publikováno v:
Circulation. 125:1102-1109
Background— In patients with severe aortic stenosis who cannot have surgery, transcatheter aortic valve replacement (TAVR) has been shown to improve survival and quality of life compared with standard therapy, but the costs and cost-effectiveness o
Publikováno v:
Circulation. Cardiovascular quality and outcomes. 3(6)
Background— In patients with paroxysmal atrial fibrillation (AF), catheter ablation maintains sinus rhythm more effectively than antiarrhythmic drugs (AADs), but its effect on symptoms and quality of life (QOL) has not been fully characterized. Met
Autor:
Matthew R. Reynolds, David R. Holmes, Duane S. Pinto, Chunxue Shi, Joshua Walczak, Ronna H. Berezin, David J. Cohen
Publikováno v:
American heart journal. 154(6)
Background Sirolimus-eluting stents (SESs) were recently shown to be superior to vascular brachytherapy for the treatment of restenosis within a bare metal stent. No economic comparison of these alternative strategies has yet been reported. Methods W
Autor:
Joshua Walczak, Patricia Apruzzese, David Cohen, Benjamin Z. Galper, Matthew R. Reynolds, Laura Mauri, Ted Feldman, Donald D. Glower
Publikováno v:
Journal of the American College of Cardiology. (17):B229
The EVEREST II randomized trial showed that percutaneous repair of the mitral valve with the MitraClip® device (Abbott Vascular, Santa Clara, CA) reduced mitral regurgitation less completely than conventional surgery, but was associated with superio